PFRM3 · PROFARMA DISTRIB PROD FARMACEUTICOS S.A. · Insider Trading
You came from your AI assistant. Add Equibles to it and ask about this data directly, free.
Monthly trading in PROFARMA DISTRIB PROD FARMACEUTICOS S.A. securities by its controlling shareholders, board, executive officers, fiscal council and other statutory bodies, with their related persons. Each body files as one; no one is named.
Monthly trading
Shares and units each body bought and sold in a month, the reais it paid less those it received, and its holding at the month's end. A month with no trade by a body is left out.
| Month | Body | Security | Bought | Sold | Net value (R$) | Held at end |
|---|---|---|---|---|---|---|
| Jul 2024 | Executive officers | Common shares | 500 | 0 | +2,545.00 | 440,740 |
| Jun 2024 | Executive officers | Common shares | 2,400 | 0 | +12,389.00 | 440,240 |
| May 2024 | Executive officers | Common shares | 25,600 | 1,500 | +140,087.00 | 437,840 |
| Jan 2024 | Executive officers | Common shares | 0 | 200 | -1,048.00 | 696,048 |
| May 2022 | Executive officers | Common shares | 2,500 | 0 | +9,074.00 | 413,940 |
| May 2021 | Executive officers | Common shares | 0 | 115 | -695.75 | 279,808 |
| Mar 2019 | Controlling shareholders | Common shares | 0 | 77,800 | -9.23 | 34,657,969 |
| Feb 2019 | Controlling shareholders | Common shares | 0 | 95,100 | -426,603.00 | 34,735,769 |
Transactions
Every movement each body reported in any of the company's own securities, options, debentures and stock loans included. Quantities are negative when they leave the body's holding.
| Date | Body | Transaction | Security | Quantity | Price (R$) | Value (R$) |
|---|---|---|---|---|---|---|
| 2026-06-17 | Board of directors | Left office | Common shares | 0 | 0.00 | 0.00 |
| 2025-05-19 | Board of directors | Took office | Common shares | 0 | 0.00 | 0.00 |
| 2025-04-15 | Board of directors | Left office | Common shares | -1 | 0.00 | 0.00 |
| 2024-07-01 | Executive officers | Purchase | Common shares | +500 | 5.09 | 2,545.00 |
| 2024-06-20 | Executive officers | Purchase | Common shares | +500 | 5.24 | 2,620.00 |
| 2024-06-03 | Executive officers | Purchase | Common shares | +1,900 | 5.14 | 9,769.00 |
| 2024-05-24 | Executive officers | Purchase | Common shares | +1,400 | 5.52 | 7,728.00 |
| 2024-05-17 | Executive officers | Purchase | Common shares | +3,800 | 5.85 | 22,230.00 |
| 2024-05-16 | Executive officers | Purchase | Common shares | +3,000 | 5.91 | 17,730.00 |
| 2024-05-15 | Executive officers | Purchase | Common shares | +6,300 | 5.77 | 36,362.00 |
| 2024-05-14 | Executive officers | Purchase | Common shares | +1,500 | 5.93 | 8,895.00 |
| 2024-05-13 | Executive officers | Purchase | Common shares | +2,900 | 5.81 | 16,849.00 |
| 2024-05-10 | Executive officers | Purchase | Common shares | +6,700 | 5.84 | 39,128.00 |
| 2024-05-10 | Executive officers | Sale | Common shares | -1,500 | 5.89 | 8,835.00 |
| 2024-01-02 | Executive officers | Sale | Common shares | -200 | 5.24 | 1,048.00 |
| 2023-04-27 | Fiscal council | Took office | Common shares | 0 | 0.00 | 0.00 |
| 2022-05-13 | Executive officers | Purchase | Common shares | +2,500 | 3.63 | 9,074.00 |
| 2022-05-01 | Executive officers | Took office | Common shares | +131,632 | 0.00 | 0.00 |
| 2021-05-31 | Executive officers | Sale | Common shares | -115 | 6.05 | 695.75 |
| 2020-08-31 | Board of directors | Other increase | Common shares | 0 | 0.00 | 0.00 |
| 2019-03-26 | Controlling shareholders | Sale | Common shares | -50,000 | 0.00 | 4.50 |
| 2019-03-25 | Controlling shareholders | Sale | Common shares | -27,800 | 0.00 | 4.73 |
| 2019-02-28 | Controlling shareholders | Sale | Common shares | -4,400 | 4.34 | 19,096.00 |
| 2019-02-27 | Controlling shareholders | Sale | Common shares | -2,100 | 4.25 | 8,925.00 |
| 2019-02-26 | Controlling shareholders | Sale | Common shares | -21,600 | 4.27 | 92,232.00 |
| 2019-02-08 | Controlling shareholders | Sale | Common shares | -60,000 | 4.58 | 274,500.00 |
| 2019-02-07 | Controlling shareholders | Sale | Common shares | -7,000 | 4.55 | 31,850.00 |
27 transactions reported between Feb 2019 and Jun 2026. Checked 2026-11-18 23:17 UTC.